These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27190810)

  • 1. The Er/Ki-67 Proportion in Breast Tumours - An Immunohistochemical Study.
    Rachna ; Rai MK
    J Clin Diagn Res; 2016 Apr; 10(4):EC06-9. PubMed ID: 27190810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study.
    Naik PS; Deshmukh S; Khandeparkar SG; Joshi A; Babanagare S; Potdar J; Risbud NS
    J Midlife Health; 2015; 6(4):178-83. PubMed ID: 26903759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XIAP and Ki-67: A Correlation Between Antiapoptotic and Proliferative Marker Expression in Benign and Malignant Tumours of Salivary Gland: An Immunohistochemical Study.
    Bagulkar BB; Gawande M; Chaudhary M; Gadbail AR; Patil S; Bagulkar S
    J Clin Diagn Res; 2015 Feb; 9(2):EC01-4. PubMed ID: 25859460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
    Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
    Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative indices and oncoprotein expression in benign and malignant breast biopsies.
    Brower ST; Tartter PI; Ahmed S; Brusco CM; Bossolt K; Hayden C; Bleiweiss I
    Ann Surg Oncol; 1995 Sep; 2(5):416-23. PubMed ID: 7496836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of diagnostic utility of imprint cytology in paediatric renal tumours with special references to Ki 67 proliferative marker.
    Maity N; Das C; Mukhopadhyay M; Parvin T; Saha AK; Mukhopadhyay B
    J Lab Physicians; 2018; 10(4):437-442. PubMed ID: 30498318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of oestrogen receptor-beta in invasive breast tumours].
    Péter I; Számel I; Péley G
    Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.
    Shaaban AM; Sloane JP; West CR; Foster CS
    Am J Pathol; 2002 Feb; 160(2):597-604. PubMed ID: 11839580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
    Buck A; Schirrmeister H; Kühn T; Shen C; Kalker T; Kotzerke J; Dankerl A; Glatting G; Reske S; Mattfeldt T
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1317-23. PubMed ID: 12271413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological significance of estrogen receptor status in axillary lymph node metastases of invasive ductal breast cancers].
    Horst HA; Horny HP; Gent HJ; Sellschopp C; Hedderich J
    Klin Wochenschr; 1988 Dec; 66(23):1160-6. PubMed ID: 2850408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.
    Shaaban AM; O'Neill PA; Davies MP; Sibson R; West CR; Smith PH; Foster CS
    Am J Surg Pathol; 2003 Dec; 27(12):1502-12. PubMed ID: 14657709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers.
    Vitak B; Olsen KE; Månson JC; Arnesson LG; Stål O
    Eur Radiol; 1999; 9(3):460-9. PubMed ID: 10087117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of estrogen and progesterone receptor protein levels in carcinomatous and adjacent non-neoplastic epithelium of the breast: a histopathologic and image cytometric study.
    Smith FB; Puerto CD; Sagerman P
    Breast Cancer Res Treat; 2001 Feb; 65(3):241-7. PubMed ID: 11336246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours.
    Focke CM; Decker T; van Diest PJ
    Histopathology; 2016 Nov; 69(5):849-861. PubMed ID: 27270560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology.
    Saccani Jotti G; Fontanesi M; Bombardieri E; Gabrielli M; Veronesi P; Bianchi M; Becchi G; Bogni A; Tardini A
    Int J Biol Markers; 1992; 7(1):35-42. PubMed ID: 1349907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, p53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with special Reference to Papillary Thyroid Carcinomas.
    Dwivedi SS; Khandeparkar SG; Joshi AR; Kulkarni MM; Bhayekar P; Jadhav A; Nayar M; Kambale NS
    J Clin Diagn Res; 2016 Dec; 10(12):EC14-EC19. PubMed ID: 28208864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.